• RCE – Remote Cardiac Enablement © 2024
  • About
  • Team
  • Press
  • Contact Us

About us

RCE.ai, an AI based med tech company works towards the early detection of heart attacks. We have re-imagined the way various biomarkers are monitored in the blood using a non-invasive transdermal technique. The AI enabled real-time cardiac assessment empowers emergency medicine physicians and cardiologists in the early assessment and appropriate risk stratification of patients presenting with chest pain. The company is currently conducting clinical studies and undertaking premarket efforts.

Address: 2292 Faraday Ave, #19, Carlsbad, CA 92008

INVESTOR RELATIONS: ir@rce.ai

MEDIA RELATIONS: pr@rce.ai

Latest posts

  • RCE Technologies, Inc. Announces Groundbreaking Advancements in Wearable-enabled Biomarker Research at the 18th Annual Biomarker Symposium
  • First-In-Human Transdermal Continuous Cardiac Biomarker Monitoring Showcased at the ACC.24
  • Groundbreaking Innovation Takes Center Stage: Winner Announced in Scientific Sessions 2023 Health Tech Competition
  • RCE presents late breaking findings at 2023 TCT Shark Tank
  • Editorial Review – Biomarkers Journal
Remote Cardiac Enablement © 2024.
  • LinkedIn
  • X